» Articles » PMID: 23012327

Chemokine-mediated Tissue Recruitment of CXCR3+ CD4+ T Cells Plays a Major Role in the Pathogenesis of Chronic GVHD

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2012 Sep 27
PMID 23012327
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Chemokines regulate the migration of hemopoietic cells and play an important role in the pathogenesis of many immune-mediated diseases. Intradermal recruitment of CD8(+) T cells by CXCL10 is a central feature of the pathogenesis of cutaneous acute GVHD (aGVHD), but very little is known about the pathogenesis of chronic GVHD (cGVHD). Serum concentrations of the 3 CXCR3-binding chemokines, CXCL9, CXCL10, and CXCL11, were found to be markedly increased in patients with active cGVHD of the skin (n = 8). An 80% decrease in CD4(+) cells expressing CXCR3 was seen in the blood of these patients (n = 5), whereas CD4(+) cells were increased in tissue biopsies and were clustered around the central arterioles of the dermis. The well-documented increase in expression of CXCL10 in aGVHD therefore diversifies in cGVHD to include additional members of the CXCR3-binding family and leads to preferential recruitment of CD4(+) T cells. These observations reveal a central role for chemokine-mediated recruitment of CXCR3(+) T cells in cGVHD.

Citing Articles

Allogeneic amnion transplantation for the management of cutaneous graft-versus-host disease with associated ulcers: A promising therapeutic strategy.

Siegmund A, Wolff D, Pagani A, Ruewe M, Klein S, Herr W Ann Hematol. 2024; 103(11):4783-4787.

PMID: 39237815 PMC: 11534900. DOI: 10.1007/s00277-024-05990-8.


Structural insights into the activation and inhibition of CXC chemokine receptor 3.

Jiao H, Pang B, Liu A, Chen Q, Pan Q, Wang X Nat Struct Mol Biol. 2024; 31(4):610-620.

PMID: 38177682 PMC: 11026165. DOI: 10.1038/s41594-023-01175-5.


Structure basis for the modulation of CXC chemokine receptor 3 by antagonist AMG487.

Jiao H, Pang B, Chiang Y, Chen Q, Pan Q, Ren R Cell Discov. 2023; 9(1):119.

PMID: 38012179 PMC: 10682378. DOI: 10.1038/s41421-023-00617-0.


Chronic graft-versus-host disease detected by tissue-specific cell-free DNA methylation biomarkers.

Avni B, Neiman D, Shaked E, Gal-Rosenberg O, Grisariu S, Kuzli M J Clin Invest. 2023; 134(2).

PMID: 37971879 PMC: 10786696. DOI: 10.1172/JCI163541.


Current perspectives on mesenchymal stromal cell therapy for graft versus host disease.

Kadri N, Amu S, Iacobaeus E, Boberg E, Le Blanc K Cell Mol Immunol. 2023; 20(6):613-625.

PMID: 37165014 PMC: 10229573. DOI: 10.1038/s41423-023-01022-z.